Intestinal inflammation alters colonic afferent nerve sensitivity which may contribute to patients' perception of abdominal discomfort. We aimed to explore whether mast cells and the cyclooxygenase pathway are involved in altered afferent nerve sensitivity during colitis. METHODS: C57Bl6 mice received 3% dextran-sulfate sodium (DSS) in drinking water for 7 days to induce colitis. Control animals received regular water. On day 8 inflammation was assessed in the proximal colon by morphology and histology. Extracellular afferent nerve discharge was recorded from the mesenteric nerve of a 2 cm colonic segment. Subgroups were treated in vitro with the mast cell stabilizer doxantrazole (10M) or the cyclooxygenase inhibitor naproxen (10M). RESULTS: DSS colitis resulted in morphological and histological signs of inflammation. At baseline, peak firing was 11±2 imp s¹ in colitis segments and 5±1 imp s¹ in uninflamed control segments (p<0.05; mean ± SEM; each n=6). In colitis segments, afferent nerve discharge to bradykinin (0.5 M) was increased to 47±7 compared to 23±6 imp s¹ in recordings from non-inflamed control tissue (p<0.05). Mechanosensitivity during luminal ramp distension (0-80 cm HO) was increased reaching 24±5 imp s¹ at 80 cm HO during colitis compared to 14±2 in non-inflamed controls (p<0.05). Doxantrazole or naproxen reduced afferent discharge to bradykinin and luminal ramp distension in colitis segments to control levels. CONCLUSION: Intestinal inflammation sensitizes mesenteric afferent nerve fibers to bradykinin and mechanical stimuli. The underlying mechanism responsible for this sensitization seems to involve mast cells and prostaglandins. 
Mast cells and the cyclooxygenase pathway mediate colonic afferent nerve sensitization in a murine colitis model. Xue B, 1, 2 Müller MH, 2, 3 Li J, 1 Pesch T, 4 Kasparek MS, 2 Sibaev A, 2 Hausmann M, 4 Rogler G, 4 Kreis ME.
Abstract
Introduction: Intestinal inflammation alters colonic afferent nerve sensitivity which may contribute to patients´ perception of abdominal discomfort. We aimed to explore whether mast cells and the cyclooxygenase pathway are involved in altered afferent nerve sensitivity during colitis.
Methods: C57Bl6 mice received 3 % dextran-sulfate sodium (DSS) in drinking water for 7 days to induce colitis. Control animals received regular water. On day 8 inflammation was assessed in the proximal colon by morphology and histology. Extracellular afferent nerve discharge was recorded from the mesenteric nerve of a 2 cm colonic segment. Subgroups were treated in vitro with the mast cell stabilizer doxantrazole (10 -4 M) or the cyclooxygenase inhibitor naproxen (10 -5 
M).
Results: DSS colitis resulted in morphological and histological signs of inflammation. At baseline, peak firing was 11±2 impsec -1 in colitis segments and 5±1 impsec -1 in uninflamed control segments (p<0.05; mean±SEM; each n=6). In colitis segments, afferent nerve discharge to bradykinin (0.5 µM) was increased to 47±7 compared to 23±6 imp sec -1 in recordings from non-inflamed control tissue (p<0.05). Mechanosensitivity during luminal ramp distension (0-80 cmH 2 O) was increased reaching 24±5 impsec -1 at 80 cmH 2 O during colitis compared to 14±2 in non-inflamed controls (p<0.05). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Conclusion: Intestinal inflammation sensitizes mesenteric afferent nerve fibers to bradykinin and mechanical stimuli. The underlying mechanism responsible for this sensitization seems to involve mast cells and prostaglandins.
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Introduction
Chronic inflammatory bowel disease (IBD) is characterized by abdominal pain and discomfort for affected patients. These symptoms are initiated by the release of an array of inflammatory mediators with subsequent sensitization of visceral afferent nerves (1) . Despite this common knowledge, our understanding of mechanisms that may contribute to this sensitization and subsequent perception of pain during intestinal inflammation is limited.
Visceral sensitivity during intestinal inflammation is most commonly studied in rat or mice by characterization of the viscero-motor response i.e. behaviour and/or muscle contraction of the abdominal wall during intestinal distension (2).
This method is indirect and the viscero-motor response as outcome parameter for visceral sensitivity may be modulated at various levels such as the intestinal wall, afferent pathways, the central nervous system (CNS), and efferent pathways (3, 4) . Contrary to this indirect and rather unspecific method of studying visceral sensitivity, models of direct recordings from extrinsic afferent nerves innervating the intestine allow to measure peripheral afferent sensitivity directly without potential modulation in the CNS. These direct recordings also allow to test specific chemical or mechanical stimuli and the effect of antagonists interfering with the action of different mediators. Thus, direct recordings from afferent nerves permit to study the potential involvement of different mechanisms specifically (5).   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Coldwell et al. characterized afferent nerve responses to the mediator 5-hydroxytryptamine (5-HT) and localized mechanical stimulation of the colon to project in the corresponding lumbar splanchnic nerve (6) . They found increased sensitivity to both stimuli during acute dextran sulphate sodium (DSS) induced colitis which persisted for 5-HT after the acute inflammation had subsided. Further studies provided evidence that transient receptor potentials of the vanilloid type 1 (TRPV1, 7, 8), type 4 (TRPV4, 9), the transient receptor potential channel A1 (10) , and protease activated receptor PAR 2 (9) on colonic afferent nerve terminals are involved in afferent sensitization during experimental colitis.
In the present study, our interest was to investigate the role of mast cells and the cyclooxygenase pathway for afferent sensitivity during colitis. We specifically investigated afferent sensitivity to bradykinin (BK) as its release and sensitizing action on afferent nerve terminals is a crucial mechanism leading to the generation of pain in somatic models (11) . For the same reason the afferent nerve response to mechanical distension was also tested.
We hypothesized that BK-and mechano-sensitivity of afferent nerve fibers innervating the colon is increased during DSS induced colitis, and that mast cells and the cyclooxygenase pathway are involved. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 colon with the mesentery attached were prepared for afferent nerve recordingsrecordings.
Technique of afferent nerve recordings
The colonic segment was placed into a custom-made organ bath that consisted of two chambers. Thereafter, the distal outlet was reopened and a minimum of 10 minutes was allowed for afferent discharge to return to baseline levels before the perfusion was stopped and BK was administered into the organ bath. BK was added in a After 2 minutes perfusion was started again in order to wash out BK from the organ bath.
Colonic segments were studied from 4 experimental groups (each n=6, one segment was harvested from one animal):
1. Vehicle pretreated control mice 2. Mice with DSS colitis 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 for 15 minutes before distension was started. The protocol was then continued as described above. Concentrations of doxantrazole and naproxen were chosen according to previous in vitro experiments (15, 16) . A potential effect of doxantrazole and naproxen on afferent nerve discharge in naïve control animals was investigated in a separate series of experiments.
Assessment of colitis
Animals overall condition was assessed by quantifying loss of total body weightbody weight between treatment day one and eight. After harvesting the colon, presence of colitis was assessed morphologically by determination of colonic length which was measured from the beginning of the ascending colon (without cecum) to the peritoneal deflection of the upper rectum, and ratio between colonic weight and length indicating thickening of the colonic wall.
Colonic segments were also harvested from separate colitis and control animals that were used exclusively for histological assessment (each n=6).
Segments were fixed in 4% paraformaldehyde and processed for histology.
Slides were stained with haematoxylin and eosin. Inflammation was assessed by a previously published scoring system (Table 1, 17) .
Drugs
DSS was purchased from MP Biomedicals (Aurora, OH, USA). Doxantrazole, naproxen, BK, and heavy liquid paraffin were obtained from Sigma Chemicals, Munich, Germany).
Data analysis
Multi-unit mesenteric afferent nerve recordings contained action potentials with different amplitudes and waveforms that were separated from noise and artefacts with the help of waveform imaging software (spike2, CED, as above).
For this purpose, units in the multi-unit signal were identified with spike2, separated and those consisting of action potentials were put back together to a multi-unit signal that was subsequently quantified.
single-unit analysis by waveform imaging software which is based on different amplitudes and waveforms of action potentials in the multi-unit recording. In brief, Spike2 software automatically sets templates for spikes in the recorded signal and then counts spikes that match these carefully defined templates selectively. Templates from signals that did not resemble action potentials eliminated as artefacts. This data is used to construct peri-stimulus histograms of individual units within the whole nerve recording. Each template is constructed from 65 data points. The parameters used when setting up templates for single action potentials could be varied but typically we require at least 60% of the data points to match the predefined template with an error of < 2%. Details of this waveform based single unit analysis were previously published (18) .
In general, multi-unit afferent discharge of the mesenteric nerve was evaluated as total discharge above baseline. Specifically, afferent nerve firing to distension was determined by quantifying the increase of peak firing frequency above baseline over a three second period at 20 cmH 2 O increments in intraluminal pressure. The response to BK was expressed as peak increase of impulses per second above baseline from a three seconds bin size. Baseline discharge frequency was calculated as peak firing for two minutes prior to distension of BK administration. Data are given as mean ± SEM and were compared by one-way ANOVA and post-hoc Bonferroni correction. Differences were considered statistically significant for p < 0.05 .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 65
Results

Morphology and histology of DSS -colitis
At day 8 after the beginning of DSS treatment, mice had developed colitis that was characterized by diarrhea and visible fecal blood which was observed in all DSS-treated animals but never in controls. Colitis was accompanied by weight loss, shortening of the colon, and increased ratio of colonic weight / length (all p<0.001; Table 2 ). Histological workup was performed in a representative series of six colitis and control animals. It revealed erosions, ulcerations, infiltration with polymorphonuclear cells, severe submucosal edema, and thickening of the bowel wall in DSS-treated mice (see Fig. 2 for representative images). The microscopic score determined by the scoring system given in Table 1 
Mesenteric afferent nerve recordings
The recording signal was characterized by high amplitude spikes with varying amplitudes and waveforms. In addition, smaller spikes were observed during recordings that could not be separated from background noise. Thus, only high amplitude spikes were further quantified and analyzed as single units by waveform discriminator software as described above. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 The average peak firing frequency at baseline was 11 ± 2 imp sec -1 in colitis segments which was higher than 5 ± 1 imp sec -1 in non-inflamed control segments (p<0.05). In colitis segments used to study the effect of doxantrazole and naproxen, discharge was 10 ± 1 imp sec -1 at baseline following doxantrazole administration (10 -4 M) and 8 ± 1 imp sec -1 following naproxen (10 -5 M) which was not different from recordings from colitis segments without doxantraozole or naproxen.
BK administration into the organ bath was followed by a robust increase in afferent nerve discharge. This increase in discharge was based on spontaneously active fibers that increased their discharge frequency and recruitment of fibers that were silent at baseline ( Figure 3A ). Peak increase in afferent nerve discharge above baseline to BK was 23 ± 6 imp sec -1 in control segments, while an increase of 47 ± 7 imp sec -1 was recorded in colitis segments (p<0.05, Figure 3B ). Afferent discharge to BK in colitis segments was 23 ± 2 imp sec -1 following doxantrazole (10 -4 M) and 31 ± 5 imp sec -1 following naproxen (10 -5 M) which was not different from non-inflamed control segments.
During continuous ramp distension, a pressure dependent increase in afferent nerve discharge above baseline was observed ( Figure 4A ). Mechanical sensitivity in colitis segments was increased compared with non-inflamed Doxantrazole and naproxen were additionally given in naïve control experiments and shown to have no effect on mesenteric afferent nerve discharge in animals without colitis ( Figure 5 ). 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 65
Discussion
This study investigates the role of mast cells and the cyclooxygenase pathway for intestinal afferent sensitivity during DSS colitis which is an established model of inflammatory bowel disease (12, 13) . Mesenteric afferent nerve discharge at baseline and to BK and mechanical ramp distension was increased during DSS colitis compared to control tissue. Afferent sensitivity to both stimuli returned to control levels when colitis segments were pre-treated with either the mast cell stabilizer doxantrazole or the non-selective cyclooxygenase (COX) inhibitor naproxen in the organ bath. A similar presence of inflammation in all colitis subgroups was confirmed by macroscopic and histological assessment with an established scoring system. Baseline discharge was higher in colitis animals compared to normal controls which was uninfluenced by doxantrazole or naproxen. This increase in discharge during colitis is likely to be attributed to an array of mediators released during intestinal inflammation such as cytokines, biogenic amines, prostanoids, leucotrienes, nucleosides etc. that have all the potential to sensitize afferents (19, 20) . As doxantrazole or naproxen only inhibit subgroups of these mediators, uninhibited agents are likely to be sufficient to maintain sensitization with subsequently increased discharge at baseline. Alternatively, differences in afferent discharge in the presence of these antagonists may simply be not big enough to be unveiled at baseline in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 contrast to more pronounced responses that are triggered when additional stimuli are administered.
We established a technically challenging novel in vitro preparation to record from afferent nerve fibers from the mesentery of the proximal colon. Previous reports described multi-unit afferent nerve recordings remote from the colon i.e. from the pelvic or splanchnic nerve (6, 8) . The advantage of this novel setup is that afferent nerve signaling was recorded directly and close to the site of its generation, minimizing potential modulatory neural input and allowing a precise localization of the corresponding area of the colon which gave rise to these afferent nerve signals., where afferent nerve signals originated from.
As for other experimental setups serving to record from colonic afferents in vitro (14) , it was indispensible to add the L-type Ca 2+ -channel blocker nifedipine to the organ bath because otherwise spontaneous colonic motor activity triggers artificial increases in afferent nerve discharge that render interpretation of afferent nerve responses to specific stimuli impossible.
Abundant previous work documents that nifedipine does not eliminate afferent discharge to an array of inflammatory mediators sensitizing intestinal afferents (18, 21, 22) . However, mesenteric afferent firing to more complex stimuli such as intestinal ischemia may be reduced by nifedipine, potentially by modulation L-type Ca 2+ -channels which may inhibit mediator release from immune cells (23, 24) . Thus, we cannot rule out that nifedipine may have had an attenuating effect during colitis, however, as all groups received this agent in an identical fashion, modulation of afferent nerve responses by doxantrazole and naproxen can nevertheless be attributed to these agents.
Serosal superfusion of the preparation with BK elicited a robust afferent nerve response which was increased in colitis animals compared to controls. BK is released during inflammation and secondary to tissue damage (25) acting subsequently as a key mediator for the generation of pain (11) . It binds to two G protein-coupled receptors which were named B 1 and B 2 (26) . The B 2 receptor is constitutively expressed and mediates afferent nerve sensitivity in naive animals (26, 27) . Increased afferent sensitivity to BK during colitis suggests that other inflammatory mediators may have sensitized afferent nerves to BK. These are likely to originate from mast cells as mast cell stabilization by pretreatment with doxantrazole resulted in an afferent nerve response which was similar to naïve animals. Among these mast cell mediators, prostaglandin E 2 (PGE 2 ) is a likely candidate as expression of Cox-2 is upregulated during DSS colitis and PGE 2 was previously shown to sensitize the mesenteric afferent nerve response to BK in naive animals (27) .
Indeed, inhibition of prostaglandins with naproxen also reduced the afferent nerve response back to control levels as observed during doxantrazole pretreatment. Furthermore, prostaglandins are known to be released during 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 inflammatory responses that are predominantly brought on by mast cells (19, 20) .
Sensitization of the afferent nerve response was also observed during continuous intraluminal ramp distension. This way to test mechanosensitivity excites different populations of afferent nerve fibers i.e. parasympathetic and sympathetic afferents plus centrifugal fibers projecting to the prevertebral ganglia (28). The latter population is small and its contribution to the afferent nerve response was previously shown to be neglectable (29), while the bulk of afferent firing consists of low-threshold parasympathetic afferents and wide-dynamic range and high-threshold afferents of sympathetic origin (29, 30, 31). Thus, afferent nerve discharge at low distension pressures stems predominantly from parasympathetic afferents and at high distension pressures (representing a noxious event) from sympathetic afferents (30, 31).
In the present study, the afferent nerve response was sensitized over the whole pressure range in colitis animals compared to controls. This suggests that both types of afferent nerve endings were sensitized, i. e. parasympathetic and sympathetic afferent nerve endings.
Increased responses during mechanical ramp distension may be explained by a permissive action of other proinflammatory mediators that were released during DSS colitis. Among these are several mast cell mediators such as 5-HT and histamine which are known to sensitize parasympathetic nerve endings (14, 18, 21) , and prostaglandins and kinins (27) which are known to sensitize predominantly sympathetic afferents. Furthermore, some mediators such as adenosine exist that have the potential to sensitize both parasympathetic and sympathetic afferents (32, 33). As for bradykinin, afferent nerve responses to mechanical ramp distension were reduced by both, the mast cell stabilizer doxantrazole and the cyclooxygenase inhibitor naproxen. There are several possible explanations for this phenomenon that both drugs worked. One is that DSS colitis triggers the release of a "soup" of inflammatory mediators that all sensitize afferents in a joint action. Thus, reducing different components by different inhibitors in such a "soup" may have a similar effects on afferent nerve discharge to bradykinin and mechanical stimulation. Another likely explanation is that mast cell action on afferent nerve terminals works predominantly via prostanoids from mast cells. This would also explain why both, pharmacological mast cell stabilization and inhibition of prostanoid release have a similar effect on afferent nerve discharge.
In conclusion DSS colitis is accompanied by inflammation that is characterized by morphological alterations of the proximal colon. Afferent sensitivity to BK and to mechanical stimuli of different intensity is increased during DSS colitis suggesting that parasympathetic and sympathetic afferent nerve fibers are sensitized during DSS induced colitis. The underlying mechanisms seem to 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 involve mast cells and the cyclooxygenase pathway, so that mast cell stabilization and/or COX inhibition represent potential strategies to reduce afferent sensitization and subsequent pain during colitis. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 nerves and visceral hyperalgesia. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G1288-1298 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 . 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Panel CB summarizes the afferent nerve discharge data which are given as 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   Table 1 Scoring system for histological assessment of inflammation (see reference 14)
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